How many investments has IPD Capital made?

IPD Capital has 20 tracked investments, 1 of which have exited.

What stage does IPD Capital invest at?

IPD Capital invests at the Seed, Series A, Series B stages.

What sectors does IPD Capital focus on?

IPD Capital focuses on Biotech, Healthtech, Sector Agnostic.

Where is IPD Capital located?

IPD Capital is headquartered in Aventura, US.

Who does IPD Capital co-invest with?

IPD Capital most often shares deals with Seed Healthcare, Crosscut Ventures, Lerer Hippeau, among 53 tracked co-investors.

IPD Capital

Venture capital

Aventura · Seed–Series B · 8 people tracked

Also known as IPD Capital Managed Account

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into IPD Capital

737 people in our graph share verified history with the IPD Capital team — schools, employers, funds. One of them is your warm intro.

Tom Danilekunlockedknows Howard Krass · together at University of Michigan (overlapped)

knows the team · via The University of Texas at Austin

×3knows the team · via The Wharton School

×2knows the team · via UC San Diego

knows the team · via Raymond James

knows the team · via AT&T

✨ Fox Verdict

Investment thesis

IPD Capital backs companies with strong business models and differentiates itself through an intellectual property-focused approach. The firm helps portfolio companies develop IP strategies to enhance shareholder value, including building patent 'picket fences' around critical technology, leveraging patents, trademarks, copyrights, and trade secrets to strengthen technology and brand positions, in-licensing or acquiring third-party patents to expand business models, and analyzing the IP landscape of existing and potential competitors.

Invests inBiotech HealthtechSector AgnosticUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series B

Aventura, US

Instruments

Equity

Founded

2013

Tracked investments

IPOs

Team · 8 people

from the firm's website & curated & public directories

Howard Krass· CEO, IPD Analytics & Managing Member, IPD Capital· Miami, Florida, United Statesin

Howard Krass is the founder and CEO of IPD Analytics, LLC, which since 2002 has provided patent, scientific, regulatory, and market analysis used to forecast product entry, loss of exclusivity, and life cycle factors in the healthcare and technology sectors. In 1993 he founded Intellectual Property Development, Inc. to acquire and commercialize patent rights, and he earlier practiced corporate, IP licensing, and litigation law at Nortman & Bloom in Miami from 1991 to 1996. He holds a B.A. and a J.D. from The University of Texas at Austin.

Steve Tighe· Managing Member, IPD Capital· Greater Munich Metropolitan Areain

Steve Tighe is Managing Member of IPD Capital. He previously served on the executive management committee for Global Banking and Markets at Bank of America Merrill Lynch as Chief of Staff and head of the COO organization, and earlier held roles including Head of Americas Equity Sales, Head of Americas Equity Research, and Head of Global Pharmaceutical Research at Merrill Lynch. Before Wall Street, where he began his career at J.P. Morgan & Company, he was a member of the technical staff at AT&T Bell Laboratories; he holds an MBA from Wharton and B.S. and M.S. degrees in Chemical Engineering from UCSD.

Alex Tang· General Partner

Kenny Ong· Director of Research and General Counsel· Singaporein

Ben Gindhart· Vice President, IPD Capital· Miami, Florida, United Statesin

Ben Gindhart earned a B.S. in Finance with a minor in Economics from the University of Miami. At IPD Capital, which he joined in 2020, he handles sourcing, evaluating, and executing venture investments across technology and healthcare, leading financial analysis, due diligence, and market research. He also helps build and advise early-stage companies.

Greg Benante· Investor, IPD Capital· Washington DC-Baltimore Areain

Greg Benante holds an MBA in Finance and Accounting and a BA in History from the University of Virginia (Darden School of Business). He started his investing career at CAV Angels and CAV Ventures, backing early-stage technology, healthcare, and consumer goods companies, and previously worked as an operator leading sales and business development teams at Bloomberg and Gartner. At IPD Capital, he works with founders, executives, and co-investors across the full investment cycle in technology companies.

Malan Rampton· General Counsel and Director of Research, IPD Capital· Singaporein

Malan Rampton is General Counsel and Director of Research at IPD Capital, having previously worked as an Analyst at IPD Analytics. Earlier in his career he was a law clerk for Judge Randall R. Rader of the U.S. Court of Appeals for the Federal Circuit and an attorney at Fish & Richardson P.C. in Washington, DC, focusing on patent litigation and prosecution. He also holds engineering experience from Compaq Computer Corporation and the Space Dynamics Laboratory, along with a J.D. from the University of Virginia School of Law and B.S. and M.S. degrees in Electrical Engineering from Utah State University.

Andy Bursten· Venture Capital Investor· Bellaire, Texas, United Statesin

Co-Founder of mark vc with a long career building and operating technology companies, including serving as Chairman of CyrusOne and Co-Founder/President of Coastal Telephone Company. He has served on numerous for-profit and non-profit boards.

What they invest in

from 9 of 20 portfolio companies

Healthtech ×5Digital Health ×4Consumer ×3AI & Machine Learning ×2B2B Marketplaces ×1Circular Economy ×1Climate Tech ×1Direct to Consumer ×1

HQs:United States×6

Investments · 20 tracked

founders shown can be your intro path

Allbirdsallbirds.com 𝕏NASDAQ: BIRD

Allbirds is a footwear brand that makes shoes using natural and regenerative materials such as merino wool, with a focus on reducing product carbon footprints.

Circular EconomyClimate TechConsumerDirect to ConsumerSan Francisco, US

Joseph Zwillinger(Director)Tim Brown(Founder)inRavi Thanawala(Director)Joe Vernachio(Executive Officer, Director)Ann Mitchell(Executive Officer)

Board Dan Levitan(Director)in

Co-investorsAurum Bay Bridge Ventures Climate Expansion Venture Capital Great Oaks Venture Capital K2 Global Lerer Hippeau +11 more

Alitheonalitheon.com in

Alitheon's FeaturePrint is an optical-AI technology that identifies and authenticates individual physical items by analyzing their inherent surface features without requiring labels, barcodes, or tags.

AI & Machine LearningBellevue, US

David Ross(Executive Officer, Director)inRoei Ganzarski(Executive Officer, Director)Roei G.inScot Land(Executive Officer, Director, Promoter)

Board Marcus Behrendt(Director)inRoss Collins(Director)

Co-investorsBMW i Ventures Emerald Technology Ventures Ag Shasta Ventures

Capsulecapsule.com 𝕏

Capsule is an online pharmacy that coordinates with doctors and prior pharmacies to fill prescriptions and provides free same-day delivery, with customers paying only their usual insurance copay.

Digital HealthHealthtech

Eric Kinariwala(Founder)in

Co-investorsAllied Venture Partners Flucas Ventures Reshape Socium Ventures Teamworthy Ventures

CLEARclearme.com in 𝕏

An identity company that enables frictionless experiences for users across various contexts and touchpoints.

ConsumerEnterprise SoftwareSaaSTravel & Hospitality

Co-investorsRevolution

Genalytegenalyte.com in 𝕏

Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records.

Digital HealthHardwareHealthtechMedical DevicesSan Diego, US

Cary Gunn(Co-founder and Chief Technical Officer)in

Co-investorsBioBrit Boutique Venture Partners Claremont Creek Ventures FusionX Ventures Samsara BioCapital Seed Healthcare +3 more

Jet Closingjetclosing.com

Seattle, US

ERIC BLOOMQUIST(Executive Officer)DAVID WOLF(Executive Officer)A. DANIEL GREENSHIELDS(Executive Officer, Director, Promoter)

BoardGEOFF ENTRESS(Director)DON GUTHRIE(Director)

Co-investorsFamily Angel Management Fund AIStudio

Larklark.com in 𝕏

Lark develops an AI-powered health coaching platform that delivers personalized support for chronic disease prevention and management through 24/7 text-based conversations and integration with smart health devices.

AI & Machine LearningDigital HealthHealthtech

Julia Hu(Founder)in

Co-investorsAlpha Intelligence Capital Asset Management Company CrunchFund Joyance Partners King River Capital Olive Tree Capital +8 more

Material Bankmaterialbank.com in

Material Bank operates an online platform for searching and ordering material samples, offering 500,000+ products across 300+ categories from hundreds of brands, delivered in a single carbon-neutral box.

B2B MarketplacesLogistics & Supply ChainNew Materials

Adam I. Sandow(Founder)inFarshid Tafazzoli(Founder)in

Co-investorsAdvance Venture Partners Lead Edge Capital 9Yards Capital Bain Capital Ventures BOND Durable Capital Partners +3 more

Owlet Baby Careowletcare.com in

Owlet develops baby sleep monitoring devices and software that provide real-time wellness insights for infants.

ConsumerHealthtechIoTLehi, US

Kurt Workman(Founder)in Jordan Monroe(Founder)inSPENCER TAYLOR(Executive Officer)in

Board LIOR SUSAN(Director)inEDWARD SCAL(Director)

Co-investors37 Angels Eniac Ventures Owl Capital R/GA Ventures Service Provider Capital Techstars +6 more

Persimmonpersimmon.life in 𝕏

Persimmon is a medical aesthetics and wellness platform that connects users with local licensed providers for at-home treatments and telehealth consultations.

Digital HealthHealthtechMarketplacesWellness & FitnessSan Francisco, US

Mark Hadfieldin

Co-investorsCadron Capital Partners Cartan Capital Draper Associates Seed Healthcare

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Architectural and Design Materials MarketplaceAt-home Botox treatments companyAvinewBIRDDigital Pharmacy CompanyIntegrated Chronic Disease Prevention PlatformOptical Machine Vision Software CompanyOWLTPoint-of-Care Blood Diagnostics CompanyYOU

Exits · 1

1 IPOs

AllbirdsNASDAQ: BIRD

Portfolio news

latest coverage across their companies

Shares edge higher as Nvidia results loom large – The Irish Times

Persimmon · irishtimes.com · Aug 25, 2026

Omega Ophthalmics Raises $7 Million Series A To Advance Gemini Refractive Capsule Toward FDA Approval

Capsule · pulse2.com · Aug 11, 2026

'Biometrics for things': Alitheon raises $8M to expand its optical AI tech to ID physical objects – GeekWire

Alitheon · geekwire.com · Jun 3, 2026

Frequently asked questions

How many investments has IPD Capital made?: IPD Capital has 20 tracked investments, 1 of which have exited.
What stage does IPD Capital invest at?: IPD Capital invests at the Seed, Series A, Series B stages.
What sectors does IPD Capital focus on?: IPD Capital focuses on Biotech, Healthtech, Sector Agnostic.
Where is IPD Capital located?: IPD Capital is headquartered in Aventura, US.
Who does IPD Capital co-invest with?: IPD Capital most often shares deals with Seed Healthcare, Crosscut Ventures, Lerer Hippeau, among 53 tracked co-investors.

Similar investors

Lux Capital

Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.

$100K – $100M

Roche Venture Fund

Roche Venture Fund is a corporate venture arm that invests in early-stage biotech and diagnostics companies across more than 10 countries, with a portfolio exceeding 30 portfolio companies. The fund is headquartered in Basel, Switzerland.

$648K – $3.2M

Expon Capital

Rodrigo Sepúlveda Schulz is a senior technology executive and investor who leads the international expansion of Stratio.ai, an AI-powered decision intelligence platform for enterprises and governments, while serving as president of his family office, Sepulveda Capital. He has participated in over 100 financing transactions with a track record including three billion-dollar exits and extensive advisory work across technology ventures.

$550K – $1.6M

Fluke Venture Partners

Fluke Venture Partners is a Pacific Northwest venture firm that has funded technology, healthcare, and consumer companies for over three decades, working with management teams as long-term partners from early stages onward.

$1M – $4M

EQT Life Sciences

EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.

$11M – $66M